APRIL COUGHLAN: Open Payments
NPI 1710373667 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 7 payments from 6 companies in 2025. Trend: 2023 $1,473 · 2024 $962 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $44 |
| Incyte Corporation | 1 | $27 |
| ABBVIE INC. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: ELREXFIO, MONJUVI, IMBRUVICA, Nubeqa, KEYTRUDA, RYBREVANT.
Industry payments across FL — which companies pay providers there.
